Benzenaminium, N,N,N-trimethyl-4-[[(pentamethylphenyl)methoxy]carbonyl]-, salt with trifluoromethanesulfonic acid (1:1); Pentamethylbenzyl-(4-trimethylammonium)benzoate, trifluoroacetate salt
Precursor for 4-[18F]Fluorobenzoic acid
Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere.
Store the product at -20℃ and protected from light. Short term storage at higher temperatures does not affect product quality.
Complete documentation - certificates of analysis including testing reports of 1H-NMRand HPLC spectra for each shipment.
PMBF-95-0010x 10mg per vial PMBF-95-0020x 20mg per vial note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial *Customized dispensing is available
Kiesewetter D.O. et al. Fluoro-, bromo-, and iodopaclitaxel derivatives:
synthesis and biological evaluation. Nucl. Med. Biol. 2003, 30, 11-24.
Emission Tomography Tracer for Cerebral and Myocardial Perfusion J. Nucl. Med. 1930,
Hoegberg T. et al. Synthesis of [Methoxy-3H]- and [Methoxy-11C]- Labelled Raclopride.
Specific Dopamine-D2 Receptor Ligands. J. Labelled Compd. Radiopharm. 1987, 24,
Lang L. et al. Development of Fluorine-18-Labeled 5-HT1A-Antagonists,
J. Med. Chem. 1999, 42, 1576-1586.